D.J. St. Germain’s West Pharmaceutical WST Stock Holding History

D.J. St. Germain’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.15K	Hold	6	–	–	﹤0.01%	819
2026 Q1	$1.5K	Hold	6	–	–	﹤0.01%	831
2025 Q4	$1.65K	Hold	6	–	–	﹤0.01%	823
2025 Q3	$1.57K	Hold	6	–	–	﹤0.01%	810
2025 Q2	$1.31K	Hold	6	–	–	﹤0.01%	809
2025 Q1	$1.34K	Hold	6	–	–	﹤0.01%	749
2024 Q4	$1.97K	Hold	6	–	–	﹤0.01%	734
2024 Q3	$1.8K	Hold	6	–	–	﹤0.01%	681
2024 Q2	$1.98K	Hold	6	–	–	﹤0.01%	684
2024 Q1	$2.37K	Hold	6	–	–	﹤0.01%	671
2023 Q4	$2.11K	Hold	6	–	–	﹤0.01%	683
2023 Q3	$2.25K	Buy	+6	New	+$2.32K	﹤0.01%	646

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

D.J. St. Germain's WST Position: Q2 2026 in Review

D.J. St. Germain held its West Pharmaceutical (WST) position steady in Q2 2026 at 6 shares worth $2.15K. The position accounts for ﹤0.01% of the portfolio, ranked #819.

D.J. St. Germain first reported a position in WST in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.37K in Q1 2024. 831 funds tracked by Wall St. Rank hold WST as of Q2 2026.

D.J. St. Germain held 6 shares of West Pharmaceutical worth $2.15K as of Q2 2026.
D.J. St. Germain left its West Pharmaceutical share count unchanged in Q2 2026.
West Pharmaceutical made up ﹤0.01% of D.J. St. Germain's portfolio in Q2 2026, its #819 holding.
D.J. St. Germain first reported a position in West Pharmaceutical in Q3 2023 and has held it in 12 quarters since.
D.J. St. Germain's West Pharmaceutical position peaked at $2.37K in Q1 2024.
831 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on D.J. St. Germain's 13F filing for Q2 2026, filed 21 Jul 2026.